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ABSTRACT 
N& is subkpkcw -metalwhich o m s  in soil. water, air, and in the biosphae. 
somenickel compounds have been sho- to induce tumor at injection rite in a n i d .  Lung 
and nasal cancers have knobsewed i i  workers at nickel ~6neries. The d i n g  of nickel in 
Voiq'r &y may pmsily pose filoofanim& con- especially to aqwtic W i e s  
The sublethal eftem of nickel subsuhide and nickel ore with respecf to oxidative damage, 
antioxidant and detoxim6ng enzymes were examined in shoR term studies in m. 
The rats were given nickel ~b~u16de(l00 mglrat or 200 mglrat), i.p., as a single 
dose or two dosu, 2 weeks prior to w & c e  NisW subsuffid- suppressd catalase and 
mpermdde dirmurasP(S0D) activitiss i i  cat & but not in kidney The inhibition in hepatic 
SOD showed a dose-dependent relationship. The decrease ofhepatic catalase and SOD by 
nickel mbruffide could be a reflection of nickel insult which eould make mget tisruu more 
wlnerable under oxidative mess. 
Othsrgraups ofrats were given nickel o n  (LOO. 2M) m9,rat). i.p., as a Jingle dose. 
f w ~   day^ (me& OTOVO weeks priorto W & C  Nlckel o n  Ummmt did not S e c t  lipid 
pemxidation, protein carbonyl content, aminol~ulinis dehydrame, malase, supemxide 
dismutase. glutathione peroxidare, glutathione level% glutathione reducfa~e, glutathione S- 
traoJkra~e (I-nitro-2.4-dichlomb-nq ethacrynic acid, tranr4phayl-3-butenen3+nn) in 
nn liver or kidney to any si&icant utmt. A stahtically signhicant incnase was observed 
inhNAD(?)H: quimnendumx in the gmup m t e d  with 2 0  mdmt (2 w), the 
edmcemmt rare awraged 117%. An imcdm in- also m d  in I d d w  glutathione 
Srransfcrase (I-chloro-2,4-di~mbeoneone) activity in the gmgmvps treated with 100, 200 
mglrat (2 d) and this activation m e d  to be induced in a doedependent manner It 
appear9 that nickel o n  d a u  not pose a serious foxid insylf to raD in short tam *dies and 
hence the risk p o d  to aquatic species could be minor However, long-term studies with 
rainbow trout and bivalves need to be conducted to investigate possible risks of more 
bmadde  cnvironmentll sonsem. 
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C H A P T E R  1 
1. IotlDdaetiDn 
1.1. Identity and solubility of n i e M  nod nickel eo~npoumda 
Nickel b a d v q  wbite metal b e I o ~ C g  to Group VUib of the pcripcrididi m b  Nickel 
usually has an oddation state o f m  while ~ l adve l y  stable ui- and tetra-dent nickel ions 
occur also. S d  Ldmyoickd mmpmdsan commerridiyand envimnmentally ri@-t 
(Stocppler. 1980). The wlubi ies ofeigbt Ni compounds in rrline solution rank as follows: 
NpOJ,>Nln,>Ni$Od d> WwS >X,Sd -0 (black) >X-metal > NiO b)]. The 
fwe Ni compounds. NS. M,S, NiO (black), a-metal, and N O  (wen), which are slightly 
soluble or insoluble, - assigned to two clnrra: one is the compounds with solubility 1-1 
than 5 p91ml, e.g NIO (black). X-me&. and NiO (green); the other is compounds with the 
sIi@ solubiliry ofmom than 500 pgM. e.g. NS and Ni,S, (Irhimtru el a/.. 1995). 
1.2 Sourcrs of human and envimnmentll exposure 
N i M  is a u h q u i t o u r t m e d  w h i c h o m i n  so& water, air. and in the biosphere. 
ore deposits are acunulationr of nickel sulfide minerals (mostly pentlandite) and 
laterite. Nickel is avery widely applied metal I t  provides met& and mrrorion resistance 
in  alloys. Nskel alloys and nickel plating are applied in vehicles, processing machinery, 
amamen4 tool$ elechical equipma household appllansa, and whmgc. Nickel compounds 
are also used as catalysts. pigments. and in batteriw A range of applications may cause 
human orposvren through d3km pathways. The primary nickel emission imo ambient air 
comes from combusion offoal a d  oil for heat or p o w  generabr+ thc incineration of m e  1 
and semge sludge, nickel mining and primary pmductioq steel mmufactuq elntmplating. 
fmm various rourcen M y  -he. w e  water (Henel dal ,  1991). 
The following in a list of a number of nickel-expaned -parions identi6ed by the 
National Inrtihltc for Occupatiooal Safety and Health or c o w  by means of biological 
m o n i t o ~ :  batay malien, mamicmalao, mal gascation work-, dye- dectmformen, 
elestroplnterr enameUq glass worken, iok makers, jnnllem. magnet makers, metal 
worken, nickel mine- nickel d m ,  nickel elnneltm. oil &hydrogenatom. paint m a h .  
rand blasters, spark pbg maken, qray paint- staidus nesl makers, tcnile dyes, varnish 
maker% weld-. The absorbed amwnt of nickel may oscarionally exceed 100 pg per day. 
htheoc~pafonal envimmm nickel orpowe mainly ormrr thmugh the respiratory tract. 
Nckel b m a y  emathe body thmughthegasmintesbnal tram due to poor work pmtiees 
(Grandjeq 1984). 
The concentrations of nickel in food are normally below 0.5 mg/kg &sh weight. High 
concernrations of nickel odn m moa, q 6 - s ,  some dried legumes, various nuts, and 
oatmeal. DiEemt dietary habits lead to various daily intake of nickel *om food; the mean 
dietary nickel intake in mon countries h 100-300 pdday. Release of nickel fmm kitchen 
utensils and cigarettes elabbg may a h  conuibute Ji@cantly to nickel incake (Hmel ct 
01, 1991). 
1.3. KiCLiL1 and metabolism 
1.3.1 Absorptioo 
NicM and its inorganic compounds SM be absorbed via the garuoiitufinal tract or 
Ule ~~pimtoryp%qes The parrmeral dninkUatimofvarious nickd sompovndn is m d y  
o f i i e ~ a  inmiddryso~diuonanimals. S-c uptake is not nncssariiy the critical factor. 
h o ~ e ~ r ,  becaw respiratory mention of sparingly soluble nickel is associated with the 
denlopment of mcpr, and curancov~ uptake may lead to an d e c  nrponx (Grandjean, 
1984). Kuehn& Slmdmnan(1982) ~ ~ g % m e d h t t h e i n v i ~ ~ o  d ssolution half-times ofnickel 
mmpovnds migM be used10 Matheir in vivo elimination Mf-times, sinn the dissolution 
proserr is rats limiting for the metabolism and d i a t i a n  ofthe compounds 
1.3.2 Transport 
Ihrre nickdJXidhg W o o s  in blood snum have been identified in viw and in iilm 
mdien uoing labelled nickd chloride: 
(a) macmglobulin4aund nickel 
@) albumin-bound nickel 
0 nickel bound to u i t d m b l e  ligands which is mody in the form of nickel-L-histidine 
complex 
Exchange and transfer of nickel beovccn Lhirtidine and albumin appear to be mediated by 
a ternary mmplw in the form of alhminnickd-1Histidine. It appears that the following 
equilibria may be present under physiolo@d conditions: 
nickel + L-histidine- nickel-L-hiddine 
nickel-L-histidine + albumin- albumin-nickcl-L-bistidine 
albumin-nickel-Lhktidinc- albumin-nickd + L-histidine 
An i n t m d a t e  ofthis nature may make it porslile for albunh-nickel to fransfer nickel to 
the lowmolsular-weight consfaurns of human which in Nm could hxmpon the 
m d  ion m r r  the biological membrane ( S d a r ,  1984). The equilibrium be- L- 
hid&pnickel and renun-albumin-nickel may be biologically significant. The equilibrium in 
favour of the L-hiddine-nickel compiex may be nn interprcration for the rapid urinary 
-mion ofnickel obwrved by O W i e r  01. (1973). Under physiological c d i t i o n g  the 
relative amount bound to eash constituent being dependent on the exan concentratios of 
n i a .  The nickeC~nsport site ofhrman albumin is located at the NTG-terminal segment of 
the protein involving the *NU, nitmgm imidazole nitmgm two deprotonafed pptide 
nifropenr, and the carboxyl oid- ofthe iupartyl residue ( S h ,  1984) 
13.3 Tissue distribution 
The repottr ofthe uptake ofnickel by organs have differed due to various &morn: 
the nickel compound administered, the route ~fabnorptio,, the Jpeciu ofanimal, the ddonc. 
the length of lime pn'or to sctifi~e. S m d  studies have described the ldnnicr of 
administrated nickel distribution and d a c e  in exprimmtal animals. Clary (1975) 
reported the dative dirnbution of &fter%Ch (I mgkg ~ ~ b c m f a n a , d y  f i r  5 days) 
treatment to  Guinea pig as. lddney> pituitary > lung > tiveivsr > spleen > h& > adrenal > 
testis > pans- > medulla > oblongata- cerebrum = mbellum.  Ishimam st ol (1995) 
r e p o d t b c  affa oral administration ofNi compounds containing 10 mg ofNi. about 84- 
87% oftheNi wes f o d  in the kidneys forthe NtCL Ni,SO, and NiS groups at 24 houri 
later. Themomttiotk kidneyrfortkNi,Sa NiWOJ, MWO,), and Ni-Metal groups was 
76.73.62, and 51%. r q s i v d y .  It appears that the highe* accvmvlation ofNi occurred in 
the kidney, endonine glands, lung md liver. The Ni disuibution in cash organ - related 
to the ro lub i i  of the Ni mmpund. The Ni dirvibution in the kidnyr i n w e d  with 
M g  sol*. It isdeartilat the highen sonmmtions of nickel were found in kidney 
and urine. It has &o bgn sham that nickel indvctiao of mi-soma1 heme-oxygenase 
activity is greater in kidney than in any other orgam (Sunderman el 01, 1983). A nickel- 
binding protein has been isolated, pufied and p d y  cbaracteriad (Sarkar, B . 1984). 
1.3.4 Elimination and excretion 
The elimination routes again are determined by the made of inta*e and the chemical 
fwm ofthe nickel elmpound. Urinary excretion is usually the major clearance route for the 
absorbed niclrel. Maimetal(1997) rrportedtk results ofthe 6rsr complete study of niokel 
maabolism in human subjects wing an oral sable nickel isotope (%) as tracer Evidence 
of the excretion of absorbed nickel via the gut were not found. The percentage absorption 
calculatedfromthemount of% w e d  in the k c e r  ranged 6om 29% to 40%. Urinary 
excretion over 5 d ranged fmm 51% to 82% of the absorbed dose According m Hemel 
(1991). all body d o n $  appear to have the abiity to e x m e  nickel, such as diva, weaf 
tear$, and milk Niclrel is excreted in the wine not as the flee metal, but bound to a pmtein 
that is similar to, or a 6agmnn of the soluble low relative molecular mars glycoprotein 
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d e d  *nickel in renal tbnue. Data on nick4 d o n  Juggem awoampamnent 
model as dwn%ed by O&linn et 11. (1980). 
1.4. Essentiality of nickel 
Kinhgessner and Schwgg (1980) suggested that n icM buncfionr in  the body as 
follows: 
(1)the body can stom nickel and har a mechanism to regulate absorption. especially duMg 
PWancy:  
(2) nickel eft& the efficiency ofiron ab90rptioo and consequently blood T o d o n ;  
(3) nickel defidency results in  lower activities of- e-es and in l o w  substrate and 
metabolite concentmions; 
(4) nickel deftciency can b5 induced only by v w  iow nickel contents in  the diet; 
(5) the d u d  gmwth rate because ofnickel deficiency is preceded by histological and 
biochemical changes. 
Nickel is a component o f  snzra l  e-e systems (eg m e  and rome hydrogenes) 
(Costa, 1996). Howwer, dd~ i t i f i o  o f  specifis biochemical functions in higher animals 
Crncludiihumm) fornick4 hasnot o o t b g n d i e d  W e l q  1996) The Ppeculation has been 
prerenedbyfielren(l991) Ulat nickel is needed for the COr6xation to propian+CaA to 
fom D-mBhWond-CoA in animals and/or hwnanr. Meisen (1996) suggcsfed that nickel 
can beincluded into the"qparent bendcid intake (ABn"slarr which denotes the elements 
with beneficial, ifnot esrcntial, actions tha can be uwpolatcd born animalr to humans. 

1.5.2 Etrem on the endocrine system 
Cerbohydrate metabolism may be altered in various animals with nickel chaUmge. 
Iighacemdationofoidrel i n t h e m h a s  bem f m d  following multiple imraperitonsal 
injections of nickel m a t e .  This &ding indicated a possible link of nickel with tins and 
insulinmaabohwhich IMY express ar nickel-induced elevation of serum glumse (Henel 
era/., 1991). 
The hypothalamic aact ofanimals is &o affected by nisld. Dormer .I -1. (1973) 
showed that the nickel ion is a potmt inhibitor of vcretion in v i m  in the pamtid gland 
(amylase), the isles ofLangerhpnr Onadin), and the pituitarygland (growth hormone) The 
mechanism that nickel may block exocytosis by intprfering with either remetory granule 
migration ormembme fusion and micmvilli formation war rugge~ted 
1.5.3 Renal etrecrs of o i c M  
As summatiled by Mulak (1980). aporure of rats to nickel sarbonyl resulted in 
pathological lesions dtubules and glomeruli; aminoacidutia and proteinuria assodated wth 
morphological c b n g a  were also found in Ihe g l o m d  of rats given single itiienions of 
ni& chloride were found. 
1.5.4 ElTecu on the immune W e m  
Ntckel is lolo- to be a potent allergen in both ompational and nonossupational 
exponureo. Twlls  were reported as a main target population in C B M  mice given a single 
i.m i+&nof 18.3 &g nickel chloride. Lymphpmliferative response ruppreraion to the 
B-cell mitagen and Datural Idller sell astivity redustion have been ob- due to nickel 
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chloride expo-. It war also reported that splenocyter from CD rats q o w d  to nickel 
d d e  in vino had changed blsstogenic TCDPOOW and CyroIdne pmdvnioo. It - a s w e d  
thatthe blanaga6cpropntirr offi may be  importam in nickel carcinogenicity (Enon er 01. 
1996). 
1.5.5 Mutagenicily ofniehl  eonpouodr 
Determination ofthe mutagenic effects ofcarcinogenic nickel compounds har been 
d B d t  teame nickel is a paor m-n or n-s in prokaryotic mutagenicity arrays 
(Biggart el a!., 1987). compounds are considexed to be only weak or equivocal 
mutagens (Fletcher er 01, 1994). Ravnto e t d  (1994) compared the rpontvlewr or ethyl 
methmerulfonate-induced mutants in AS52 (a Chinese hamster ovary ceU l i i )  to those 
gmemted by~xporweto nickel mmpwnds Thqr observed that nickel compounds exhibited 
M increasein gene deletions relative to paint mutations; the extent ofwbich -compound 
s p d c :  NiSO, > Ni(OIi), >Ni,&. It war also reported that some nickel compounds were 
clanogdc in *o, pmducing E h m m ~ ~ m e  aberrations, transformation and sister chromatid 
exchanger in mammalian cells Wertel el 01, 1991). In conaast to their m w k  mutagenicity, 
nrckel compounds have been shown to increase W-induced cytoto*city and mutagenicity 
and to interfere with the repair of IN-induced DNA lesions by disrupting DNA-protein 
intemiom involved in DNA dsmage recognition m e g e r  er 01, 1999). Kmeger er el. 
(1999) suggested that nickel 0 at "on-cytotodc cancsnwtions inhibits nucleotide excision 
repair and possibly cmshkrepair by interferencewith distinct reps of the respective repair 
pathways. Based on the Nang correlation between mutagenicity and carcinogenicity, 
9 
mutagenicity testing h s  been suggcnd to be "red as a p d d v e  test for Caninogcnicity 
although it doer not giw absolutely amrate nsulrs Wi th  and Bmggsr, 1984). 
16.6 Careioogenieity of nick& and i u  mmpoonds 
Sunderman(1984) rrpo~tedfbafthefoIIowing inddencw of-- ossumd at the 
inje3ionsitewiUdn two p r s a r k m a l e  Fischer cats were ea red  wirh a single i.m. injedon 
at equivalent dosages (14 mg Nilrat): nickel subsukide, 100%. crystalline nickel subsulfide. 
IMP/.; nickel ferrosultide, lom; nickel oxide, 93%; nickel subrelenide, 91%; nickel 
suffienide, 88%. nickel subnelenide, 91%. nickel sulfarenide, 88%; nickel dinulfidq 86%; 
nickd subnrwnideW~&, 85%; nickel d w ,  65%: nickel antimonide, 59%. nickel tsllunde, 
54%. nickel monorelenide, 50%; nickel subarsenide w,,As), 50%; amorphous nick4 
monosulfide, 12%; nickel chromate, 6%; nickel monoarsenida. 0%. nickel dtanatp. 0%. 
&rmoiM alloy, WO. Appmdmately halfof the tumors induced were rhabdomyo-mas; 
r k  remainder oe-d as fibrosacmmss, &mtiated sarcomas. unclasdfid sarm-, 
a neurofibrosarmma, and a fibrous hiniocytic rarsom. Siy-one perant of Ue -ma- 
bearing rats had dinant mnastases. The carcinogenic activities of the compounds wen 
m l a t e d  wi thwnickd  m m n s ,  but not with d-lution half-times in rat rerwn or 
renal cytoxll, or with phagocytic indices by rat pvitoneal macrophages in v i m .  
Onolenghi rr a/. (1974) reported a high incidence of pulmonary hyperplastic and 
neoplastic lesions in Fisher 344 rats &er exposure to nickel subsulfide (0.97 mg nickeVm3) 
for 6 hriday, 5 dsydweek over 78 weeks. 
Lung and nnsal sanrn haw bpen &md in work= at ni& rehaies. The mmon 
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are domkntly ofthe epithelid fYPq anaplastic nnd pleomorpbic tumors are seldom found. 
The Lrfonnation for other -pation expo- such as welding elecVoplaring grinding 
MIL with nickel catalysts ir less artcmivc than for nickel refining Cancer on sit= ofthe 
larymi of the stomach and of the kidney, and sarcoma of =I? h u e s  have also been 
amibuted to nickel exporun (Leonard. 1981). 
1.6. The possible mechamism involved in oickd taririty and urcioagcnicily 
1.6.1 Clreinogenicify mnrrchaniatic model oFnieM e o m ~ u n d s  
The sanimgajc pnends ofdifterenr nickel compounds appear to be ~ k e d  to the 
bioavdabilily of nickel (presumably N3 to aitisd intrasellular rites (Cart% 1991). 
Accordimg to OUa (1997). it is rem*ed that thee me two main components that could 
contribute to t h ~  dewlopment of lung cancer due to nickel exposure. 
I The genetic or epigenaic- derived h m  rhc actions of nickel compounds 
The heritable changes can be amibuted to ouo clgrsen: 
(a) direct &&fs (nickel specso): the changes which r ed1  fmm a d i m  Nia* cffect on 
DNAlchromom~ (c.g nickel s~brultide) 
(b) indirect df- (not nickel s w c ) :  the changeo which can be indirectly induced by 
nickel compounds ar a consequence of an inflammator/ response. such an DNA 
damage awed  by oxygen radicals (ep. nickel oxide) 
U. The pmmotion of cell Dmlifcrarionclicitd by cenain nickel compounds (not nickd 
specific, e.g nickel mlphate). 
Both components are q u i d  to prodwe cancer. During the oscumncs of direct effects, 
I I 
three steps ars iwolvsd: (a) the nickel compound particles are endowtized by the target 
celk (b) theendocyfio v a i c k  an aci&edbyfvsion with Lyroromer and N2* is r e l d  (c) 
the endocytic vesicles merge with the nuclear membrane deliverkg W- to the nucleus, 
&arLvly to the hetemshranmkregion ofthe DNA located in c l o s  proximity to the inner 
nucleac membrane. The following events may ensue: condenstion and methylation 
olhsncement ofthe DNA& regionwhich could resvlt in heritable inactivation of m a r  
svpprcssor gpnss; gsncration of oxygen radicals through a Ni(III)Mi(ll) mechanism which 
subsequently induces damaged baw, DNA strand brralw, and DNA-protein cmrrlinks, 
chromoromal aberrationr. 
1.6.2 NieM induce4 oridative atrera l od  antioridant ddnfcnee pmurbatioo 
1.C2.1 Intmductioo of oxidative stress and antioddmt defence svtern 
The term oxidative s e e s  is widely used in the -radical titcramre but it b rarely 
defined. In eswnss it rekn to the situation of a serious imbalan- between production of 
ROS (reactive oxygen species)lRNS (reactive nitrogen species) and antioxidant defence 
(Halliwell and Guneridge, 1999). 
1.6.2.1.1 Lipid peroridation and -late4 defence mqma 
One of the mechanisms of damage to celltdar targets by oxidative raerr is lipid 
peroxidation. Lipid peroxidation has been defined ap Zhe oxidative deterioration of 
polyunsamrated lipids'? Membranes in mkaryotes contain many m t i a l  polyunsamrafed 
fatty acids (PTJFA). Initiation of lipid pmxidation in caused by attack upon an unsamrated 
lipid ofmy species that h s  d s i e n t  -to a b m t  a hydrogen atom from a methylene 
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(-CH,) gmup. Once the he-dical  chain reaction is initiat4 ir propagates -1 the 
urmmraed lipid in c x h a d  or two ke radicals dmmy each aha to terminate the chain 
(Hdiwll and Gutteridgq 1999). The products oflipid peroxidation include highly nacfiw 
lipid hydroperoxidex H,O, hydmxyl radical, and malondialdehyds that may pmdua 
gemtoxic ag. DNAdegmdation, DNAsUand b& protein-DNAcmrr LiDkS, and 
oxidative modilicatian ofDNA bass (Mi- 1991). 
In biological systems, there udsf enzymes which are capable of conmlling the 
cytamdc &em of& oqgeo nlgenspcis, inclvding umke(CAT), glvathione prroedase 
(GSHAr) a d  supemride d i i u ~ s e  (SOD) which can proten ceUs 6om the armmulation 
ofHfihydmproddu, and svpupnoxide (Mismer ol., 1990). The advent ofoxidative Nerr 
in vrvo often leads to in-ed I d s  of antioxidant m e s  which serve to pmrecf the 
o rgmid .5 snehm thedelefaiws&N of mrsactive 0-0 species and lipid peroxidation 
pmduCIS (Barror el 01, 1991). The reaction catalyred by CAT is tk foUowing (Aebi el ol, 
1984): 
2H3O1 - ZH*O + 0, 
NAD(P)B: quinone oridoredud.s+ abo named DT d i apbo ra~ ,  whish is often 
regarded as aphase II dctadficatian system c a t a l w  a f w d c m n  reduction ofquinonw 
into hydrquinowr at theexpaueofNADH or NADPH One fUostion ofquinone dvctase 
isto diminish t h e f o d o n  ofsvpemxidc radicals in v& by r-vingquinowr. Moreover, 
quinone redustax has been implicated to help maintain ccmzyme Q in the reduced fom 
hence'+recycling" it as an inhibitor of lipid peroddation (HalliwellbL Gutterids 1999). 
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Mnal-catdyzed oxidation has been idensed as a post-t-slational soMlem 
modification of proteins which may bc impomf in sexed phyridogissl and patholo@'sal 
proses- which include the aging process, inuacelldar protein Nmwa, arthritis. and 
pulmonary diseases. Introduction of &my1 groups into amino acid residues of pmteios is 
a hall mark for oxidative modification &evin+ 1990). 
T h e d o @  w a y  is a general assay 0foxidatiM protein damage. It is bawd on the 
fict that s-a1 ROS attack &acid residues in proteins to produce products with 
carbon# gmupr (HalEweU and Gutterage, 1999). 
1.62.1.3 Glutathione and i b  metabolisiog enzymes 
Glutathione (GW isa nonproteinthiol ttipeptide, which is p-nt in high somua t ions  in 
all cells including those of liver and kidney. It has s m d  important functions e.g. the 
maintenance of sul6ydryl enzymes. intgrity of membranes against w x i d a t i v e  damage, 
ragvlation of amino acid Vansport and maintenance of intraceUular redox potential (Athar 
el 01.. 1987). M o m ,  &tathione is  -+ed as a protective sompovrnd within the body 
for the removal ofxenobioticr by forming soluble sonjugater and ficilitarting their excretion 
k m t h e  d. Theewymssatdysbgthe a b w e r n ~ u g a t i o ~  are glutathion-S-tmnsfemses 
(GSD vhi& ace bald in the cyt(u0I of her, kidney, w t  and other tisslles (Gibsoh 1994). 
Glutathione pmridsre, an enzyme that ndvces H,O, and lipid peroxi&tion like catdare 
at the upense of GSH is h w n  as a major protective system a@mt adogmourly and 
exogenously induced lipid peroxidation The reaction it catalyss is as follows (Wendel, 
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1981): 
ROOH + 2 GSH - ROH + H a  + GSSG 
Glut.thiooe d u -  regmemta GSHat Ur cxpolv ofNADPH which plays an important 
mle in maintaining a high mtio ofreduced to oddired glutathione (GSWGSSG) in normal 
cells. The d o n  catalyred is as follow (HsYiweJl and Guftnidge, 1999). 
GSSG + NADPH + W - 2 GSH + NADPP 
1.6.2.1.4 meme menbolidog system 
Hane conrtimtes the proahsic moiny ofavariety of hnnapmteinr. The list includes 
the oxygen binding proteins hemoglobin and myaglobin, catalases and a large number d 
p e m d b  and all the cytcdwmes P450. Thus, an altaaGon in the heme content ofthe ccll 
could profoundly the activity of s e v d  cellular enzymes and therefore, cellular 
functions. T h c ~ o n o f & l a r  hem content by the combination of inhibiting the heme 
biospthdcparhway (e.g. nminokvulioic wid deh$nt.ae) andtor stimulating the hems 
degradation pathmy (eg beme orygenue) by metal ions could haw a si@cant impact 
on the d (Maines. 1980). 
1.62.2 NieW induced oxidative and antioxidant d d n r e  lyrtem pertorbation 
Extensiue -dies haw been conducted inview ofthe fha Ulat nicW i n d  oxidative 
stress and permrbs antioddant defence systems. Bared on animal studies, lipid peroddaton 
inbnh liver and kidney could be induced with nickel exposum Wnra er ol. 1991; Athar el  
01.. 1987; Stiwmva cr 01, 159% Mioraerol., 1990). Nickel can alx, diminish heme I d s  
th-oughthe combim6onofhaneoxygem% activity inhibition and ALA dehydrafaw activity 
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enhancement (Tresan el 01.. 1980; S u n d m  el of, 1983: Iscan el of ,  1992; Mainer, 
1980). GSHlwelr andtbe activity ofantioddam porymss mch s GST. GR, GSH-Px SOD 
and CAT have alw, been nhoum m be f i s t e d  by nickel in a main- and timpdepsndent 
m u t e r  consumfly with lipid peroddation enhancement (Herrero el  01.. 1993; Cartana el 
d, 1989; Atharerd, 1987: Mismorol., 1991; Srivasfa~~erol., 1990; Atharelal, 1987'. 
Misraerol., 1990, Rodrigunetol, 1990; Ircanoral, 1992, 1993; Cartanaetoj., 1992;). 
1.7. Objective of the t h a b  
There is increasing mcem wer the possibility oftonic mMlr leaching fmm mine 
tailings and 6om the min- them~lves. A recent m d y  h m  a Ni mine and smelter rite in 
Nomy indicated enhanced levels ofNii Co. Cu and Zn in the land ournunding the smlter, 
in water draining fmm the mine and smelter and in fish @mum trout) caught from rites 
immediately doummeam. Nickel is lolorn to accumulate in the gill% liver, kidney. brain and 
white muscle of fish (Brothmidge er a/., 1998). 
This pmjen will involve sub-lethal toxicity studies associated with bypmductr ofthe 
mining and melting ofthe nickel rich pentlandite W. Fe. Co),S. from Voioey's Bay The 
Voioey's Bay nickel deposit is located near the maptal village ofvoisey's Bay in Labrador 
Nnufwndland, Canada Voiscy's Bay is deemed to be the mon significant mineral discovery 
in C d n  in 30 yean and dirpolal ofthe4 million tons oftailings (containing Ni. Cu, Co and 
Fe)mbepmduced mually is recogdd by DFO (Depamnem afFiheries and Oceans) and 
Emhnment Canada to be a major issue. The tailings, which have the potential to generate 
add in the preseme ofoxypn, are m be pumped by pipelin. into a number of ponds which 
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d d-to some o(1nrt to the o m .  It is p ropod  to use aqueous ruspmriow of nickel 1 
oreand nickel smLm&ideto -stheir uptake and toxicity potmtids in avaiety of wstems. 
IniMIy, ril viw -dies usigratr d b e &  out. Infomation obtdded fmm these studies 
wiU rubwquemly be ured to design long-term studips with -bow trout and bivalvps. 
O v e d  tlds mdyaimto &em!aei€the leachable a d l  as panidate I a n  forms ofthe 
metals an taka up to my men1 and pore r i s k  of more bmadxale emrimnmental concern. 
It is worth noring that the studierwith nickel ore would involve a m*tum*tue ofmetals and the 
-- oforganisms to it may be we ftomthe rerpowto pure metal sompevnds 
u d  in most smdis. 
My r e a c h  is the f i r s  step ofthe project aiming to pJfablirh the toxic response of 
FaD to nickel ore with respect to oxidative damage, antioxidanf and detoxisating e v e s .  
With regard to carcinogenicity assessment. nickel subrulfide has been suggested as the Ni 
compound which presentsthe highen carcinogenic poteotial &titie to other Ni compounds 
(OUaetol, 1997). The candnogenic pomcy ofall compounds is directly related to their 
ability to enter cells, which is correlated with compound solubility. It is portulated that the 
manner in which nick1 is complued in the ore and its solubility (or lack of it) will haw a 
significant impact on how it &s organisms. In this regard, the effenr of nickel ore may 
resanblethat ofnickel ~ybsuSdesina the latter is also insoluble. Therefon, the rerpotm of 
rats to bath nickel s u b d d e  and nick4 ore was investigated in my project. The following 
biochemical parameters were craminsd: 
(I) ALA dehydratarc 
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(2) antioxidant system which motaim: satalase, SOD, glutathione peroxidasc 
(3) glutathione lwei 
(4) glutathiom S- t rans fa  
(5 )  glumthione nducfw 
(6) NAD(P)H: quinone ductarc 
(7) lipid peroxidation 1-1 
(8) pmtein carbony1 somenr 
2. MATERIALS AND METaODS 
2.1 M.t.2ri.b 
2.1.1 Chernirnls 
DTT. EDTh HEPES, pmtease inhibitor cocktail, T B 4  GSK OPT. 
dbimphqLydm&e, ethyl a-te, ALAIn/dmshlocide, PMAB. H a .  svccinic anhydride, 
ferriqtoshmme c, hypoxanthine, -thine o x i h  sodium e d c ,  glutathione reductare, 
NADPH, NADK GSSG, CDNB, DCNB, dhasrynic acid. uanJ4phenyl-3-buten-2-one, 
F A D 4  DCIP were punhased fmm Si@naChmidCo (St. Louis. MO, USA). Nickel ore 
war 6omPCMRCANMET Ws 1.233 MA; C4  0967 wt%; Co. 0.041 wt%: €t. 0.41 uglg 
Pd, 0 37 uglg; Ag, 4 30 uglg ). Ntckel arbsuffide ( Ni,S, ) was purchased bom Inco 
Temnical SaviccpLimited (hfissir~auga, Ontario. Canada). Nl other chemicals were of the 
hiBheJt grade sommersially available. 
2.2 Methods 
2.2.1 Anillla1 treatment 
Male Spragu+Dawley rats (165-175 g) were obtained bom A n i d  Care Sexvice% 
Mwod UniwrriiofNewfo~ndland, and maintained on standard laboratory rat chow and 
warn-. Nickel elbarl6de or Ntckel ore w administered intraptitoneally (i.p.1 as a 
suspension inl: 1 glycerol and dm (0.9% NaCI). The various treatments are listed below: 
1) Nickel subsuffide (100 mglraf ), i.p. , as a single dose, sacrificed in 2 we t s ,  
2) Nickel subrulfide(200 mp,mp,f), i.p., as a single dope, sacrificed in 2 weeks, 
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3) NicM subsultide (200 m#mt), i.p., dailyfor 2  day^ sacrificed in 2 weeks 
4)Nickel are (1W mP,mt)), i.p.. ss a dngk dose, rasriliced in 2 we&% 
5) Nickel ore (200 Wmt) ,  i.p.. ss a dose. sawiticed in 2 weeks, 
6) Nickel ore (200 mdmt). ip., as a single dore. sacrificed in I week 
7)Nckei o n  (100 m h t ) .  i.p.. as =single do* r a d c e d  in 2 days, 
8) ore (200 ms/m ), i.p.. as a single dose, r a d c e d  in 2 days. 
Co rn1  rats & anequivalent amomofvehicle (1:I glycerol-&=). Rats were 
W f o r  12 hours prior to bdng lrilled by cervical dislocation. Liwrr were perfused insiru 
with 0.9% NaCL. 
23.2 Repant ian of samples 
2.2.2.1 Pmpsrntion of liver qtosol nnd the rrmplu Pr mnaurelnent of GSE, lipid 
pvoridrtioo and ALA dehydntnsc aetivily 
AUUle fouowhg p d u r e s  for Ulc preparation of liver qtosol and kidney cytarol 
were performed at 04'C according to the melhod described by Rahimrula et ol. (1979). A 
pieceofeach l iv~rfamu~d 0 3 9) w s  taken immediately after prrfurion and fmzm 1apidiy 
in liquid nitmgen for the array ofdutathiooe eontent muruwment (ALerbmom 1981) 
The h a n  livesamplesthethe were stored at -70°C before use. Another piece of each livu 
a m d  0 3 g war put individually imo the specec b& which will be dercriW in senion 
2.2.2.2 for pmteio urhonyl assay .The nrt of the liver war washed in saline. After 
the liver war minced into fine pieces and homogenized in 3 wiumer (wlv) of 0.1 
M potassium phosphate b W  (pH 7.4) by a motordriven Poue;Eljwhem homogenizer. 
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One ml of the h o m o m e  uas fakeq mhed with EDTA (&al u)ncmUati  I m. and 
stored (at -709: before use) for lipid pemxidatiom muavmncnt  "ring the MDA-TBA 
method The rcst ofthc homogenate was cmhifuged at 2,000 g for 5 mi& +hen at LOP00 g 
for l o  min. 
L i r  cytosol was imhted km the 10,WO g Jupematm by cenhifugation at 105,000 
g for 75 min. An aliquot of 0.83 ml of each ti- cytorol was &en and individually mhed 
with 0.02 mlo1250 mM DTT (dithiothreitol) and 0.15 ml glycerol. The m*ture was thm 
60- in liquid nimgen and stored at -700C before use for the m u m a t  of M A  
dehgdnfsde activity (SIUSB, 1982). 
2.2.2.2 Preparation of samples for pmteio rrrbanyl content mea rumro t  
The tiwr mpletal tainthe d o n  2.2.2.1 uas homogenized in 3 volumes (wlv) of 
bufmwhich mntaidHEPES (10 mmoVL, pH7.4). NaCl(137 mmoVL), KC1 (4 6 mmoVL). 
W P O ,  (1.1 mmoVL), magnesium svlphats (0.6 mmoVL), and ethylenediaminefetc885etic 
acid (1.lmmoVL). Pmt- inhibitor c o c W  (16.66 mV L) was also added to inhibit 
proteaser inthe ramplu. Theliver homogemewz e g e d  (4'C) 6m at 10.000 g for15 
min The supernatant used for the determination ofpmtein carbony1 content wss recovered 
aRer mtrifngation of the 10,000 supernatant at 105,000 g for 5 min st 4'C. The samples 
were kept at -70°C before us5 (Ro-h el 01.. 1997). 
2.21.3 Preparation arlddney qtorol 
The kidneys fmm each rar were excised and pooled separately in icecold O.IM 
pomshnphorphate bufhr(PH 7.4). TheIddqs -then sliced in halfand the cortexwas 
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cae fdy  cut o f f h m  the medullawith -son. The nod cortex was m i n d  into fine pieces 
aod homogenized in 3 valvmer (wlv) of 0.1M pata~sivm phosphate but?= (PH 7.4) by a 
matardriven Potter-Eljevhem homogcnim (2 XIS pa: at a rening of 5). Ln ramc cares. 1 
td ofthe h o m o ~ e  wsr taken, mixed with EDTA(&al concentration I mM), and stored 
at -70°C before the measurement of lipid peroxidation. The rest of the homogenate was 
oentrifiged firs at 2,000 g for 5 miR then st  l0,OW g for 10 mix Kidney cytosol was 
i poWfmmUe  10,000 g supematam by cma5~gationat 105.000 g for 75 min and stored 
at -70% before "re. 
2.2.24 Preparation drurchoyhted qtwhrorne c 
Partially sucsinoylated qtochmme c war made according to Kuthan el ol (1982). 
Finely grained sussinis anhydride (0.42 mmol. 42 mg ) was added to a vigorously stirring 
solution of ferricytochmme c (8 pmol IW mg) in 40 ml of icccold 30 mM potauium 
phosphate buffer (pH 7.6) over I period of30 min. The pH offhe ~)Imfion was kept at 7.6 
by titration with 2 M KOH. ARer the ranian is camplete, the solution was stirred for a 
further 20 min and then t r a d e d  to a dialysis bag and dialyzed overnight agairut doubly 
d i a e d  water conmining 0.1 mM EDTAf 4% The modified cytochmme c preparation was 
concentrated about 3-fold by uhdtration through PM 10 membraneand stored at -20'C. 
2.2.3 Pmteh determimatian 
The protein concentration of all sample% wan determined by the method d Lowry 
eroL (1951). 
22.4 MUsvremrnt of lipid pcmrldrtioo 
Lipid peroxidation inthe samples was monitored by mearutiq the I d  of MDAas 
described by Uchiy- and Milma (1978). Inn LO ml test mbe, 0.5 ml (5 mg protein) of 
homogeme wasmixed with 3 ml of l% H,PO. to keep the pHofthe medium at abu t  2.0. 
One ml of0.6% aqueous TBA war thm added and the m*ture was heated at IOVC for 45 
min. A8ercaoling 4 ml of ~ ~ ~ O I W B J  added and the mMlrs was shaken vigorously. The 
hu-1 phasc was sqamed by ~ g a 6 0 0  (2.500 g for I0 min) and its abrorbancc at 535 
and 520 nm was meamred The h abwrbann ar there fwo wavelmgthr was t&m 
to avoid interference due to thc protein Tewmcrhoqpmpane was used as an utemal 
standard to dsulate the MDA-TBA value ar MDA is released by the hydmiysir of 
tctramethoxypropane. The level of MDA-TBA is expressed as oanomole of MDA pcr mg 
protein. 
2.2.5 Mearurrment of GSa contar in liver homogemate 
GSHcontem in liva h o ~ e w a s m e a r u r e d  ascording to Hissin and Hilf (1976). 
A portion of250 mg liwrti- was homogmized on ice usinp a Polytron homogeizer The 
rolutiw u s e d f o r h o m o g ~ o n ~  of3.75 ml ofO.IM rodiim phosphate buffer (pH 
8.0) containing O.W5 M EDTA and 1 d of2S% metapborphotic acid (HPO,) The total 
how-wascen~ged(4OC) at 105,WO gfor 30 min to obtain the ylpemMant for the 
assay ofGSH An 0.5 ml aliquot of the rupemstant was mixed with 4 5 ml0.1M sodium 
phosphate bvtfer @H 8.0) containing 0.005 M EDTA The final assay mixture (2 0 ml) 
contained 100 111 ofthc dilnfcd tissue supernatant. 1.8 ml of phosphate-WTA buffer. and 
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loo pl of the OPT (0-phthalaldehyde) soiutio& containing 100 pg ofOPT. M c r  thomugh 
mixing and incubation at mom temperature for IS min, the solution was transferred to a 
quam cuvene Flue-ace at 420 nm (slit 10) was detamined with advation a 350 m 
(dt 5) (wale is fixed at 1.0). A standard curve was constmcted by using kwwn mourn of 
GSH inrtead ofdLhtedtiwe homogeme (O,O.l, 0.5, 1.0, 1.5.2.0 ug GSH per2 ml reaction 
mirmre). 
2.2.6 Meaauremcnt of protein urbonyl content in liver honogenrte 
The determination of pmtdn arbooyl wment was wndvcted according to L e A e  
el 01. (1990). An aliquot of 1 mg protoin in 0.15 ml0.lM potassium phorphafe bu&r (pH 
7 4) was tnired wilh 0.6 ml of I0 mM2,&dhimphenyUIydm&e in 2 M H C  The blank was 
run by a d d i i  2 M HCl instead d2.4d'mitmphenylhydradne. The mixture (MI allowed to 
s t a d  at mom temperature for 1 hour. with vonexing every 10-15 mi& Then 0.75 d 2 0 %  
TCA war added. The mixturr was centrifuged at 11,000 g for 3 mi" and the supematant 
diwarded The pellet was washed 3 times with 1.5 ml efhanolahyl acetate (l:l) to remove 
freereagerd. dowingthe m p l e m  stad 10 min- each c e e ~ g a t i o n .  The precipitated 
pmteinwas redkolved in 0.9 ml of  6 Mguanidii in 20 mM potassium phosphate (adjusted 
to pH 2.3 with tduoroaseiis acid) at 37'C for 15 min. Any insoluble material was removed 
by centrifuetion for 3 min at 1 L,OW g. A specrmm ofthe sample in the wavelength w e  
of360-390 m war obtained with the complnnentary blank sitting at the reference position. 
Thecarbanyl cornea was dculated fmmthe-m absorbance using a molar absorption 
coefficient of 22,000 M' mi'. 
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2.27 Mnvurrment of rllryme activities 
2.2.7.1 delta-Anioolrvulinic scid debydmnre 
Ths v t  ofdeltam~imlewlinic add ddqmhme was cartied out following 
the method dumbed by Saroa(l982). The asray stock mixme was made ar foU0w: 0.8 ml 
of loo m M  ALA, 0 2 ml of1 M DlT and 8.0 ml of 50 mM salium phosphate b u s r  (pH 5.8) 
weremhed and adjusted to pH 5.8. Then the ~ l v m e  ofthe solution ir brovght up to 10 ml 
*the - b e  T h e d e d  EhrGch'r reagent war made ar foUows 0.7 g HgCL was 
disrolved in 168 ml acetic acid (wmed  gently). M a  cooling 40 ml of 70% HCQ war 
added and the mirmrs wa diluted to 220 ml with acetic acid One gram of p- 
dhnethylaminobenzaldehyde PMAB) war dissolved in 55 ml ofthe above solution prior to 
use The modified Ehrtich's reagent was kept in a brown bottle b-nnc it is light sensitive. 
Theasray mhfure contained 0.5 ml ofthe above assay stock m*run or array aosk 
m*aue devoid of ALA hydrochloride and 50 111 of the m p l s  prepared by the pmcedure 
mentioned under sample preparation section 2.2.2.1. The m*Nre was incubated at 37% for 
60 min inthe dar*. Oncand a halfml of6% TCAsolution containing O.IMHgC1, was added 
to stop the d m  Merseobiki~gatioo at 1,WO g for 5 mi& an aliquot of I ml nupernatant 
was mixed with 1 ml Ehrlich'r reagent. Atter exactly 10 min at 23 T when the msximal 
absorbance ofthe W c h  -PBG@orphobilinogen) ~olour salt developed. the absorbance was 
measured at 553 nm (extinction m&cient 6 1 x lO'W1an-') . 
2.27.2 Canlase 
Cataliucm liver and bi&ycytosol was m a d  according to Aebi, 1984. Catal-c 
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activity was ednwed by d g  the b r b a o c a  dezeas of% at 240 0 (20 "C) The 
assay was -ed out in a 3 ml N- contdthg 50 mM pofBSsiurn phosphate b&u& (pH 
7.0) aod anappmpriateamnmt ofpmtein (0.005 mg livercytosol pmtein or 0.01 mg kidney 
-1 pmnin). The d o n  was started by addiIion oftbe wtmol (mixed well with a plastic 
paddle) . The absorb- decrease was m d e d  for about 1 mi" The molar eninction 
caefficienr of H,O, is 43.6 W' m-'. 
2.2.73 Supemride dilnuNe (SOD) 
Enn/me activity war mearvred by a modification ofthe method dercnid by FLohe 
and Otting (1984). Solution A was prepand as follow 5 pmol(0 68 mg) hypo-thine in 
10 mlO.OO1 N rodiumhybideand 2 vmol d e d c y t a c h r o m e  c (see part 2.22.4) were 
admixed with 100 m1 of 50 mM phosphate b e  (pH 7.8) containing 0 1 m M  EDTA 
Solution B war, a freshly prepred solvtion of xanthim oddme in 0.1 mM EDTA (0 2 
unitlml). The asay was carried out at 25 'C in B 3 ml spectrophotomefer N v m e .  Solution 
A (2.9 ml) war pipetted into the mvme followed by 50 p1 oPrample and 10 pl of 3 mM 
%dim adde (final conc~tration lo-= M; to block pemddases). me reaction was started 
with 50 pl ofsolution B (xanthinc oddase). ARer miang the absorbance change at 550 m 
was recorded. Unda these defined conditions, the amount of SOD (cyfasol) required to 
inhibit the rats o f d u c t i o ~  of cyrochrome C by 50% is d&ed as 1 unit ofactivity. 
2.2.7.4 Glutathione prmriduc 
Glutathione peroddase activity was measwed m described by Flohe and Ounrlsr 
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(1984). The following solutions are pipned into a I ml avette: tive h u d d  pl 0.1 M 
phmphate b&(pH 7.0). I00 pl e-e sample (0.02 mg liver cytosal protein or 0.04 mg 
lddney cytosol protein), 100 pl glutathione reductax (0.24 unit). and exactly I00 pl of 10 
mM GSH . One milimolar rodium adde was added to block otalax in lhr sample. The 
m*Nre was preinmbated for 10 min at 3YC. Thereafter, 100 pl 1.5 mM NADPH in 0.1% 
NaHC03 war added and hydropermdddepadem mtmmpioo ofNADPH was monitored 
for 3 mhr The overall d o n  war started by ad- 100 pI of pcewmed 1.5 mM hydrogen 
pemddesalution and the b m  in absorption at 340 m was monitored for about 5 min. 
Thenonmn/misrrastionratewas correspondingly assessed by replacing themqme sample 
by buffer The activity ofthe enzyme was calmlated an faUows: 
A= 0.868 (change of p JAD~I [GSHlO f ) (V,NJ 
Note. [GSHI.: initial soncsnrarion ofGSH 
Change of[NADPHl It :the rateofdecrease inNADPH urnmuation 
V, - the volume. ofthe incubation mixture 
V. the wlumer ofthe enzyme sample 
The extinction coefficient of NADPH at 340 m is 6 22 mM-' m -' 
22.7.5 Glotathiooc d u r t s s e  
The assay war sprried out in 3.0 ml mvme. at 25 'C and contained (final 
cmcemations): 50 mM potassium phosphate buffer (pH 7.0). 0.2 M KC1 I mM EDTA I 
mMGSSG, wtmo!icpmtein@w cytosal pmtein 0.4 mg or ldddey cytorol protein 0.2 mg 
)and 0.1 mMNADPH . The rate of the reaction was followed by wording the decrease in 
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absorbance of NADPH at 340 nm as GSSG war redused to GSH Wrthington and 
Ro-eyer, 1974) 
2.2.7.6 Glutathbne S t r a m f e m e  
Glutathione S-uansfrrare activity war measured a~ deeribd by Habig el d. 1.1974) 
uimg (IDNB (I-chlom-2,4dbhbe-), DCNB (I-h-Z,4dichlorobazbazbaze), ethacrynis 
acid andmm4phenyC3-butehZ-one as acceptor rubstrater. AU ranions MR carried out 
at 30°C in 3 ml rpenmphotomtcr c u ~ t t e p  and wen inkieted by the heddiri G S H  A 
complete assay mhtun without e m y m  rand as h e  m m i .  AU the substrate solvtianr were 
prepared with ethanol as sol-. 
2.27.6.1 CDNB as substrate 
The 3 d mimue contained 0.1 M potassium phosphate b u m  (pH 6.5). 1 mM 
CDNB. 0.005 mg liwrcytoroi protein or 0.04 mg Lidney cytosol pmtein and I mM GSH. 
Thenaaionwasfoliowrdby measuring the change in absorbance at 340 m. The milimolac 
extinction coefficient is 9.6 M' mi'. 
2.2.7.6.2 DCNB as substrate 
The 3 ml mixture contained 0.1 M potassium phosphate buffer (pH 7.5). 1 mM 
DCNB, 0.1 mg liver cytosal pmtein or 4 mg kidney cytorol protein and 5 mM GSH. The 
reaction was followed by measuring the change in absorb- at 345 m The milimolar 
eainction ~ e 5 c i e n r  is 8.5 mM" cm-' 
2.2.1.6.3 Etheyn ie  acid 
The 3 ml mimrre contained 0.1 M potassium phosphate buffer @H 6.5). 0.2 mM 
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ethn& acid. 0.4 mg liver cytosol p t d n  or I mg kidney cytoml p m &  and 0.25 mM 
GSH. The reanion was followed by m a r i n g  the change in absorbance at 270 m. The 
dholarortinction coeflicient is 5.0 &'m-'. 
13.7.6.4 mos-e~e11yl->bufen-2-0ne la aubsmn 
The 3 ml mimrre contained 0.1 M potassium phosphate bu&r (pH 6.5). 50 pM 
d p h m y - 3 - b u t ~ 2 a o n + 0 4  mg IivmqmsoI p r o t e i n  mg kidney cylosol pmtein and 
0.25 mM GSH . The d o n  was followed by measuring the change in absorbance at 29(1 
m. lhe milmolar ortinmion co&cient is 24.8 dvf'm-'. 
1.1.7.7 NAD(P)E: qulnolle dueuse  
T h e m y  was carried out ar,dusnIed by Bensoneral(1980). The reaction mixwre 
contained in a final w l m c  of 3.0 ml : 25 mM Itis-HCI (pH 7.4). 0.7 mg bovine serum 
aUnrmin (BSA) at pH7.4.0.01% by wImeTween 20. 5 10 
pM dicoumml, an appropriate amount of sytosol(0.1 mg liver cyrorol protein or 0 2 mg 
kidney cytosol pmtein), and 40 $4 dichloroindophmol P C P ) .  The assay was conducted 
at 25 F with andwithout dimmar01 Thedi-mamlkmitive p m  ofthe activity was faken 
as a mearureofthe quinone ductam advity. The initial velocity of lhe reduction of DCIP 
wa. -red sp~ctmphotomenically at 600 musing an extinction coefficient of2.1 x LO' 
M' cm.' 
3. RESULTS 
Rats in the nickel s u b d d e  treated gmup g e n d y  showed v a y  slowweight gain 
Mmpared with the control gmup. Fluid in the abdomen w f o r d  in one rat in the group 
treated with2W mgnickd wbslEde 0 doses, 2 w); another rat in the m e  p u p  appeared 
vny & Rats m e d  a.th IW mg nickel err (I dor+ 2 w) (UJ had si@mf slower weisht 
gain (a.thS0.436.49 pscmt mpared  with 56.64 11.30 pacent in control group) Wei* 
gain in raU treated wifh 2W mg nickel ore (I do% 2 w) 0 rhowed no si@& difference 
Ennpsred wifh the ~ n m , 1  gmup. Overa4 Ni ore treatmmt appears to exen no effect on rat 
Wngh gain. 
3.1 In ~w a e r t  of oirkel are on LN) Itvrls in rat liver and kidney hhonqenab 
M D A l d  wsnmcaaued in liwr and kidney homog~nata to obrerve the etTM of 
rdckel ore injectionupon lipid oddatinr As shown in Table 3.1, a s i@mt increase in liver 
lipid psroudafion by nickel elore wk. &Served only in one of the three gOups treated with 
nickel ore 200 m@nf i.p., as one single d o e  and mri6ced in 2 week. No siflifisant 
changer in lipid peroddation 1-11 were observed in the other ouo repeated trial In fact, a 
signisifisant decrease in liver lipid woddation levels was obrerved in the gmup treated with 
nickel ore 200 m@mf i.p., as one single dose, sacrificed in 2 days. The other trestmenfs of 
100 m g a r m  mgnidrel o r e s h o d  a fiend toward9 lower lipid peroddation levels in bofh 
kidney and liver dfhmgh the dfirencss were not rigiri~ant. OveralC it appears that Ni ore 
d o e  not increase MDA levels in fhe liver or kidney oftreated rats. 
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Table 3.1 
The effect of nickel ore onlipid pcraridation in rat liw and kidney homogenate (pmoVm8 protein) 
Valuer shown are means i S D ofduplicate damninstions from 6 individual rats per nickel ore treatment group 
denotes s significant differenffi(P < 0.05, t test) 
** d e n o t e s  significant diff-cc (P < 0.01, t t ea )  
' - 8  denotes a significant differmffi (P < 0.001, t test) 
LH 
mnuol 
h t e d  
KH 
m m l  
Unfed 
LH: liver homogenate 
KH: kidney homogenale 
N i m  
2Wrndral 
I w  
113.00+ 
2600 
245.Wf 
1lO.W 
mtdane 
, 
Ni,$ 
]wmdrnt 2  
nndw 
n d d m  
Nime 
ZWrn&hol 
2w 
(1) 
nndana 
mdone 
NhS, 2OOmghrt 
2w 
mldane 
notdone 
Niom 
2Wmgirnl 
2w 
(11) 
11417r 
3991 
2 3 6 . e  
31.61** 
noldanc 
Nl,s, MOmfil 
2daecn 
2," 
m d o n l  
mndone 
Nbac 
200mgml 
2," 
(1111 
201.15* 
6390 
142.2r 
3964 
649.35+ 
229.50 
54225+ 
, 52.65 
Nlor. 
IOOm%/rsl 
2rr 
(I) 
m t d w  
m t h  
N l a c  
IOOmghol 
2 ,  
(11) 
201.15* 
6190 
I38M)t 
6 4 8  
64935* 
229M 
Si2 106 
, 81 30 
N i m  
IWmghnf 
2d 
211.65t 
2385 
241.61f 
40.91 
571.OSf 
40.95 
405,456 
, 91 15 
Nlae  
200mgh3l 
2d 
271.651 
2385 
220.5f 
48 IS' 
511051 
40.95 
415.351 
, 8505 
3.2 h vivo &st of nickel are upon F i r  homagmate protein carhngl caofcot 
Therqar ts  inwrrigahgthe&st ofnickel on hepatic protein carbonyl content hwe 
mt been found in a rwiw ofthe literature Pmtein carbony1 cornem in rat liver - messured 
h @adarm asrerr the &eCt of nickel ode on mddafive pr& damaxe c o n ~ ~ ~ ~ e e t l y  with 
lipid peroxidation. As rho- in Table 3.2, no significsnt changes in liver protein carbonyl 
content were observed for dl the Veatmentr of nickel ore compared with controls There 
results are in keeping with the lack of lipid peroxidation changer mentioned in pan 3.1. It 
a p p m  that nickel ore treatment does not ahance afthc oxidation oflipids and proteins. 
Table 3.2 
The e M  af nickel are on protein carbanyl content in rat liver(pmoVmg protein) 
Values show are means tS .D of duplicate determinations from 6 individual rats p a  nickel ore treatmew group 
* dmota a significant difference (P < 0.05, t test) 
'* dmobr a significant differmc. (P < 0.01, t test) 
**' denotes a significant difference (P < O.WI, t test) 
3.3 1" vivo cKe t  of ai&l ore upon ALA dth*nuw activity in n t  liver 
The aaivi~~ofALAdehydrata~e is lolm to be inhibited in several tissues including 
liwd kidney bu administntion ofnick1 chlodde to rats Waines, 1977). Although ALA 
dehydratase is not reganled as the regulatory mryme in the heme biowthcsis pathway 
(Maines, 1980). the alteration of this e-e anivity will indicate heme biosynthesis 
pmmbatioo HOWOO, o imwIubk bmofnicbl  (eg. the fom in nickel ore.) may WI rather 
differently from the soluble one. AS shown in Table 3.3, no significant changer in rat liver 
ALAdehydratasc m i d y  wen observed for all themaments ofnickel ore compand with 
convol gmup. 
Table 3.3 
The effect of nickel ore an ALA dehydratase aaivity in rat liver and kidney (mol  PBGhourlmg protein) 
Values shown are means* S D, of  duplicate detemimtions Bom 6 individual cats pet nickel oretwatmmt group 
denotes a significant differencep < 0.05. t test) 
'* denotes a significant difference (P c 0.01, t test) 
*** dmoles a signifisant difference (P < 0.001, (test) 
3.4 1" vivo effect oimickei s ~ b ~ u l ' d e ~ n d  niekei om 0 n t  nnIimidaat uuylna 
Thelwelr ofa wietyofm cytmlic aqnm were m c d  after nickel subnrl6de 
or nickel ore ma- to obrerve the @re change ofmioxiimf defence systems. Soluble 
nickel compounds such as nickel acefafg nickel chloride, have been reported to affect the 
biological antioxidant Mtemr in a 6 and timbdepmdent m m e r  Wsa ef 01.. 1991; 
R i d  erol. 1990). The &kf of imoluble nickel compounds, e.g. nickel subsulfide, upon 
antioxidant enzymes has not bcm reporred. 
3.4.1 caw.* 
As demwstmfed in Table3.4andFigu~3 I, a d&-t decreasein rat liverc~talase 
d t y n r u r r e d  nubwqucntto nicl lsubddemarmsnt  (2W "g'raf single or twice dose, 
d c e d  in rwo w&) Them - a tmd  tovvards ca r a l e  inhibition in rat lddney although 
thed- were not statidsally signif- after nickel mbsulfide exposure. HYYYY, the 
suppression in the liver did not osm in a dosdependm manner. nickel ~vbnvffide ZW 
mght(onedoze, 2 w) s h o d  asuppsiooof54% while nickel subsulfide 200 m@at (two 
doses, 2 w) showed a 39% dmcape. 
A significant d - e  occurred once in rat liver and kidney our of three identical 
trials in which rats were treated with niskd ore ICQ mglcaf 200 "g'raf ( s adced  in two 
weeks). The gmvp treated with nickel ore 1W d r a t  (sacritced in 2 days) showed a 
signifirvlt de-e in kidney but not in liver Overall, it ap- that nickel subruffide 
decreases oatalase activity in liver but not in kidney. whereas nickel ore does not fin 
catalase d v i t y  in either organ. 
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treatmenl 1 100 mgrrat nockea subsuifoe (one dose 2 w n.31 
2 200 mglrat nickel r~bs- l rde (one dose 2 w n.3) 
3 200 m g m  nockel r ~ b s ~ l f a e  (NO dore$ 2 w n.3) 
- F0.05 mmpB'ed With arntm1gmup *w 
Figure 3.1 me effect of nickel subuifide on rat liver 
caalaqe activity (umoUminlmg pmtein) 
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3.4.2 Supenride DismuUsc 
Msmcrol. (1993) reported that SOD astivity in male F344MCr rat kidney and liver 
didnot show evident changer affainaaperitoneal injmion ofnickel amate. In my studies 
nickel subruffide (200 m9,raf one dore or two doses, sacsced in 2 week) riflcantly 
decreased rat liwr SOD activity as rho- in Table 3.5 and Figure 3.2. The mppression of 
SOD ktivitywas Ugherinthe&semp (39.6%) than in the onedore p u p  (33.6%). 
A siflcanr enhancement in SOD activity- observed in rat kidney only once foIIowing 
nickel ore treatment (200 m#mf a. a single dose, &ced in 2 weeks). The rest of the 
experimentd gmups did not show m y  signi6sant changes. Hence it appears that nickel 
rubsulfidesv- SOD w i n  rat liver but not in Lidoey. Wckel ore does not appear to 
aegt SOD activity s i ~ ~ t l y .  
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treatment: 1: 100 m@mt nickel subruifide (one dore. 2 w, n=3) 
2' 2W mplrat nickel rubsulfide (one dose, 2 w, n=3) 
3: 200 mgrat nickel subsulfide (two doses, 2 w, n=3) 
Figurr 3.2 The affact of nickel subsulfide m rat liver 
SOD activity (unitlmg protein) 
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3.43 GluUUlione peroxidme 
The study repaned by Mipra er ol(1991) emphasized the imponsnce ofGSH and 
GSH-Pxioprwdag nicke-induced oxidative cdl damage mmpared with CAT and SOD. 
As shown in Table 3.6, glutathione pemxidase activity showed a ri@cant increa~e in rat 
liver &er the treatment with nidrel mb&de (100 m a  as a single dose, deed in2 
weeks). Also, a si@rult induction in IivaGSH-Px dvity occumd in the group mated 
with nickel ore (lC4 m9/mt. as I ninigle dose, sacrificed in 2 days). AU othergmupr did not 
show a d@sm change in glutathione penxidare activity. 

35 I,, "im elTed afnickd om upon GSE Iw* io rat liver hool-ate 
. . Admwmtion of nickel to rats has bem shown to initidly reduce hepatic glufathione 
l m l s  followed by an increascm I d s  2 to 3 tLnes above n o d  m e $ .  1980). My studies 
showed that m significant changes in rat liver homogenate occurred &er Rickd o n  
trratmen ( lW mdmf ZW mdraf deed in2  daysor2 we&) ( s ~  Table 3.7). It app- 
that nickel ore does not affect rat heoalic reduced GSH levels. 
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3.6 1. vivo etrect of nkkd om upon duhthione d u r U w  
GRironeofmcial mqmeswhich &as cdlular GSH levels besause it cao reduce 
oddiad gluwhione (GSSG) to the reduced fonn (GSH). In inbibition afGR by ni&l 
chloride has been reported ( C a m  et 01.. 1989). In vim rmdies showed quire inconsinent 
d t r  Bothinhibition and &cement have bem reported due to nickel qown Wrra, 
etol.. 1991; Athar, sol., 1987). In my rmdia(Tab1e 3.8). in the three similar trials with 200 
mdraf nickel ore (2 w). the results H e r e d  each time. A significant increase, a % S c a n t  
decrease and no effest in nu WGRBCfivity were all a b e d .  The two similarhials with 
nickel ore lC4 mglrat (2 w) showed aimram inmmeonse and a significant d a m  once 
in rat liver GR anivity. GR activity in rat kidney was not evidently &&zed. A significant 
increase ossurrsd only once in rat Idddey GR activity ofthe gmup treated with Ni ore 200 
&at (2 w). The-n Torthis i n c o n s i ~  in the repeated "ids is not clear Overall, one 
rmn ~ ~ c l u d e t h a t  nickelore does n a  induce biologically signifisant changes in GR activity 
This observation i s  in keeping with the results ofGSH meawemart. 

3.7 In vivo ensf of nickel ore opon NAD(P)B: quinooe reduaase . 
Smdia examining the relationship bemeen NAD(P): qu(uiwne dunare  and nislrd 
exposre were not found in the literarurp rrvinu. Since thir e w e  is regarded s a 
component of biolo@d detoxifying oyptm, its activity after nickel o n  treatment war 
maxed and cornparedwith the mnflol @np. As shorn in Table 3.9 &Figure 3.3. nidrel 
ore m m e n t  ofratr did not induce any si&cant change in rat E d n e y N W ) H :  qvinone 
dunarc Inthethrperimr7ar~ds using 200 &rat nickel ore (2 w), the enzyme activity in 
m l i w r i n b  s i @ m r d y t w i c e ( t h e ~ c a t e  waz averaged as 117%); the other 
group showed a trend of in- in rat liver although it was not statistically r imcant .  In 
the two trials with I00 ms'ra! nicM ore (2 w), the mryme activity in rat liver inaeased 
sipX-tly once and showed auend ofincrease once although not significantly The vials 
with 100 mght,  200 &rat nickel ore (2 d) s h o d  a decreasing t m d  but thir was nor 
si@CaPd. Si@icam e&cts wenmt obrerved in rat kidney following nisM o n  treatment. 
Overall, it appears that nickel ore is able to i n c w  rat Iiier NAD(P)H: quinone reductase 
activity in a time-dependenf manner. 

treatmem I: nickel ore 1 W rnglrat(2 w, n=6) (I) 
2:nickel ore 200 rnalrat 12 w. n=61 (11 
3 nlc*el ore200 rnglrat i2 N. n=6i jli) 
4 n 6c.4 we 1 W mglrat (2 w n-6. (Ill 
5 nc*e ore 200 rnglrar (2 w n=6) (111) 
Figure 3.3 The effect of nickel ore m nt liver NAtJlP)H: quinone 
reductas* activity (nrnoVrnilllrng protein) 
3.8 B viuo eiT& of oickd ore u p 0  gI~t.thiome Smsmsfe- 
The differential responses among the substrata of hepatic GSTE to a g m  variety 
of xenobioticr have be- wdl established (I- 1993). Rather contradictory results in the 
litmum have been reported regarding the GST response to nickel exposure. Enhancement 
and inhibition- bah observed ( A h ,  1987; Misw 1990).The reason forthe dhTerence~ 
o b p e d  among there studies may be antibutable to differences in the age, main and 
nutritional status of the animals used mcaq 1993). 
3.8.1 With CDNB rsrubsmte 
CDNB is the most important substrate for the dnnonnMti0n of multiple form of 
GST- 1993). As shown inTabk 3.10 and Figure 3.4. a si&- decrease in m liver 
GSTactiviw(wim WNB as subMe) d in the nickel ore upated g m p  (100 mdraf 
ass single dose, Panifid in2 web)  but onlyonce in -td uials. GST astivity inc-ed 
S ~ C M *  in rat Iddney dme to the treatment of nickel ore (both 100 Br 200 mglrat group, 
as a dnglsdass sacrificed in 2 days). It reem that nickel ore treatment could increare GST 
anivity(CDNB) in rat Iddmyshortly aftpr treatment (2 d). The treatment ofran with nickel 
ore for 1 weekor 2 weekrprior to m d c e  does not have my evident on GST activity 
(CDNB). 
Table 3.10 
The effect of nickel ore on glutathione S- trmsferase (CDNB) activity in rat liver and kidney cyfosol 
LC: pmol/midmg protein 
KC: nmo!lmidmg protein 
Values shown are mans * S.D. of duplicate determinations fmm 6 individual r p  
denotes a significant difference (P < 0.05, t test) 
** denotes a significant difference (P c O,OI, t test) 
"'denotes a significant difference (P < 0 001, t tert) 
LC: liver cytosol 
KC: kidney cytosol 
0 1 i 
treatment: 1. nickel are 1 W mglrat (2 d, n.6) 
2: nickel ore 200 mglra (2 d, n.6) 
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Rgure 3.4 The cRact of nickel ore on rat kidney GST (CDNB) 
ntivi* (nrnol/minlmg protein) 
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)=""I - 
3.83 With DCNB u robrmte 
As shown in table 3.11. nickel o r e f m f  did not cause any si@cm changes in 
car liver and kidney GST (DCNB) activity. Thk observation is in keeping with the study 
reported by Iwan =I d(1993). 
Tabk3.11 
The dfect ofnickel ore on glutathione S-trsnsferase (DCNB) activity in rat liver and kidney (nmoVminlmg protein) 
Valuer shown an means * S.D. ofduplicate detmninations from 6 individual rats per niokel ore treatmmt group 
L C m M l  
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108.24 
*I836 
1.82 
N.20 
1.97 
N.22 
N i m  
200rnprmt 
2," 
(11) 
14120 
*13.38 
122.82 
f11.71 
rmdane 
Nior. 
200m&l 
2rv 
(Iii) 
164.15 
*2405 
15826 
k1505 
rmdax  
N i m  
IWm&t 
2d 
78.55 
111.64 
86.20 
114.23 
mdmc 
N i a .  
22Wrnml 
2d 
18.55 
+I164 
83% 
r564 
- 
nadmc 
3.8.3 Efiaclynir acid 
h shown inTable3.12. oidrelore Uurment did not s u e  any significam changerin 
cat liw & kidney GST (efbpsrynic add) activity Iscan er a1 (1992 aod 1993) reported a 
ionease hGST (F.AA) &nickel chloride tmammt in rat liver However, we should keep 
in mind that inxrluble r i a  compoundn may an diierently 60m wlnble me. 
Tablef 12 
The dfen o f ~ & e l  ore on giursthione S-transfmsc (ethacrynic acid) activity in  rat liver and kidney o)narol (nmoVmidm~ protein) 
Valua shown are means + S.D. ofduplicate detwminations from 6 individual rals per nickel are treatmen1 group 
LCmUol 
Ucatrd 
KC 
mu01 
tad 
denotes a ~lgnllicsnr dlffntnee (T c 0 05, I lest) 
'' acnoto a s,gn~6can1 d~fferencc (P < 0 01, I test) 
"'denotes a n o n l c a a  d , l rcncc  (P < 0001.1 ten) 
LC: l ivw cytswl 
KC: kidney c)lowl 
Ni,S, 
~ w ~ y m  2," 
not dom 
mldmc 
Nc,S, 2OOrndmt 
2w 
noldonc 
 he 
NI,S, 2Wmghol 
2 h s  
2 w 
noldon~ 
mldonc 
Ntorc 
IOOmdraL 
2," 
(1) 
53 W 
'199 
52W 
13.16 
42.W 
a W  
45.W 
1.91 
N i m  
IWrnb/raf 
1%" 
(11) 
2610 
f7.82 
27.50 
f737 
60.2 
3 
51.1 
S.51 
N i m  
200 mghol 
I w  
52 38 
f1.67 
54.88 
h3.M 
43.65 
1 1 8  
42.65 
a583 
N l m  
2OOmgirat 
2 s  
(I) 
51 M 
f3.B 
5650 
*3.76 
4Z.W 
f l W  
1 5 M  
a3.18 
N i m  
200 moat 
2w 
(11) 
2125 
f5.38 
22.50 
112.77 
mldonc 
N i m  
200m@ot 
2 r  
(ill) 
26.10 
f182 
1038 
a11.49 
W.20 
1312 
62.70 
t 5  I1 
N i m  
100myr~t 
2d  
36 88 
f2.86 
31.38 
+2.74 
12W 
i 4  14 
45m 
+9.90 
N i m  
2~mghat  
2d  
36.88 
f2.86 
31.18 
*1.23 
42W 
f4.14 
r 6 w  
P.63 
3.8.4 with mn&phmyC%boten3dne as a u b m t e  I 
As shown in Tabk 3.13, thechanges in rat liver GST (tranr-4-pholyl-3-butete-3-one) 
activity woe mt ur- in hcec &Is with nickel ore (ZW wgls'af sr a single daw 
. deed in 2 web) A signiS-t increase, a ri+cant d m -  and no riflcant change 
in rat liver GST activity ( tmm4phhyl-3-butut3-one) were all observed. Kidney GST 
(-4phenyl-3-bmh-3-one) activity did not show any significant changer foUouring the 
treatment with nickel ore. In general. nickel ore treatment appeared to have no effect upon 
GST (~an&phenyC3-bufen-3-one) activity 
Table 3.13 
The effect of nickel ore an glutathione S-transfense (trans4-phenyl-3-b~fen-3~0ne) activity 
i n  rat liver and kidney cytosol (nmaVminlmg protein) 
Values shown are means aSD. ofduplicate determinations h m  6 individual rats per nickel ore tresment w u p  
LCmnml 
tealed 
KC 
mnUd 
wold 
denom a ~ignlficanl dtRocnv (P s 0 05, I test) 
'' denotes a r gnlcant dllrence(P < 0 01, t an) 
"'dcnolesa u$n#hcanl d~ftrence (P P OOni, t 1e5) 
LC. liver cyfasai 
KC: kidney ~y foso l  
Nl,s, 
1oornwI Zw 
nctdrmr 
nndonc 
N~,s, zwrn@at 
2w 
noldme 
 MI^ 
Ni,S> 200mgha< 
2dosa 
2 r  
natdono 
no!& 
N ~ o n  
I W m w t  
2w 
(I) 
2062 
f591 
15.21 
f2.40 
091 
M.32 
080 
+a 10 
Nimc 
IWrnghot 
Zw 
(11) 
21.7018.26 
21.8215.58 
1.26M.18 
I.4lM54 
~ t m c  
zmrnw!  
i n  
2142 
*I49 
2256 
&386 
nndone 
Nim 
2Wmwc 
Z w  
(1) 
20.62 
6 9 1  
14.52 
*2.41. 
091 
M.12 
0.64 
, a 1 4  , 
~harr 
Zoomgha 
2," 
(11) 
17.77 
f262 
15.81 
*I70 
notdono 
Nimc 
? W n w ! 2  
r 
(111) 
217018.26 
31.7%597* 
1.26M.38 
0 98M 28 
~ i m c  
l ~ r n @ a ~  
2d  
15.29+220 
15.4K+2.59 
notdone 
~ i m  
zwmgha 
2d  
15.29*2.20 
14.5~1.80 
no tdm 
C E A P T E R  4 
4. DISCUSSION 
4.1 In viva etrsu a f r l i e M  aubsullide 
The mcchnoism ofnidrsl tmdcity and cardnogmicity has gained some dmi6ation in 
mew-. Numemvs mdis -dingthetodcityand msinogmioity of nickel subsuffide 
hnvebeen mnducfed. Withregard to carcinogenicity assessment, nickel mbsuffide har beeo 
suggetedas dteNi compound which presents the highest carcinogenic potential relative to 
other Ni compounds (OUer a 01, 1997). In viw, nickel s u b d d e  is likely to be readily 
d o &  and nddirrolnd by the target sells ml t ing  incffician d&vq ofNi" (Cona and 
MoUenhauer, 1980) Howwer, studis on the in vivo eEM of nickel rvbsuffide on oddative 
damage to lipid (e.g. lipid pemddation) and protein (e g. protein carbonylr formation) and 
antioxidant def- spans an few (Rodrigunel 01, 1996; Teirrier el 01, 1994; Shirali er 
01, 1994; Sundermanel ol, 1985; Bmsonberol, 1986). Most ofthe studies were performed 
with water soluble nickel compounds. 
In viw aTea ofnickel rubsulfide on rat antioddant defense yatystans (e.g. caralare. 
SOD, GSH-Px) miwentigated in my &. An o v d l  rwinv ofthe rwults led to the 
conclusion that nickel subsulfide s-s to be able to suppress catalare and SOD activityin 
rat liver but not I d d w  (Table 3.4, Fwce 3 I, Table 3 5, Figure 3.2). Inhibition dcatalare 
did not show a dose-dependent Rlatianship, wh-r inhibition in SOD showed a 34% 
suppression for the one-dosage p n p  and am% supp-ion €or the hv~oslgegroup. It
also appears that nisld subsulfide does not exa a si@cam effect upon GSH-Pr. 
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Acodbg to OUsdol(199'1). nickel rubsu16de~ddbcefSdmr at promoting both 
heritablechanges aod cell prolifemion during its carcimgenetir, The involvement oforygen 
radicals generated thmugh a Nio/Ni(UJ redox meshanism could induce damaged bases, 
DNA strand brralg DNA-protein mosskks and chromosomal abarationr (OUu el 
199'1). Huang or ol. (1994) reported that nickel rubpulfide in& the connnwtion of 
oxidants in CHO d r .  Hydrogenprmddeis one ofthe formed oxidamr in thir system. Lipid 
hydmpemxids arpmducts o f i n d u d  lipid peroxidation may also be produced thmugh the 
adon of nickel in intact celh. It is l o l o w  that catala~e, SOD and OSH-Px appear to work 
inconjunction minwiring rhs cell's exporun to reactive intermediates of oxygen reduction 
Wmer ol, 1990). Hnrce the diminishmat ofhepatic CAT and SOD by nickel subsulfide 
in my studies could be a reflgtion of nickel kwlr which would make target times mare 
vvlnerable under oxidative mess. 
It is assumed that Be toxicity elicited by niniliel is in clow nlafionship dB nickel 
concentration in targel tissues. Howwu, thir is not always the cape. In the rep* by Mirra 
el d (1990). the-Nde o f W 0  was not pmportional to fhe nickel ~ ~ C O C O C O C O ~ Z ~ ~ O O  (nickel 
acetate) in the reapenive organ. Both liver and kidney r h d  the samcLW increase 1- 
(1 10.130%) while the co~entration of nickel in kidney was 10 fold higher than in liver. In 
my studie~, no evidem &idant defence *em changes were showed in rat kidney which 
suppJedly is themain exsrrfingorgan and henceprsshg a higher concennation ofnickel. 
The nact -n for this phenomenon is not slsar One pssibiliry for thir difference could 
bethe t% that w M e  ofthe nickel s u b d d e  had dissolved and hence the mncmvdt io~~  
in the kidney (as well as otherorgms) nady for exmioq  WR low 
Irwasnported thar microsoma1 heme o x y 8 e ~ d ~  activity in rat lddney increased 1.5 
told OneMdraftainWrsnd inj.ction of 10 mglraf nicW subrulfide. At 2.3.4 w& after 
i n ~ i n j ~ o n o f N i , s ,  r e d  h e  orygenasc activities did not dee r  riflCMfly 60m 
the mrrespondimg valua in mntml rats (Sundcnnan d ol, 1983). Heme constitutes the 
psth#ic moiety ofavariety of hnnoproleira 'The list includes satalase, several pemddaser 
and a large n u b  of cytoshroma P450. A permbation of h m e  metabolism may be 
involved in the shanga in rat hepatic malase amd GSH-Px activity after nick4 rubrul6de 
adminimtion However, M e r  investigations will be ngded to pmve tb. 
The mode of nickel nubwlfide action could be amibutsd to i n  metabolism kinetics 
&or adminimatian. It was reported that &er p m e r a l  mabnent of Wi3S, to rats, the 
excretory half-time of% d e a d  fmm %,S averaged 24 days: NI (Itl slowly dissolved 
in body nuids and was excreted in the mine (ICueuehn and S u n d e m a ~  1982 ). 
4.2 In v*o cN=t of michl ore lo rat liver and kidney 
The nickel ore sample used in my mearch m obtained fmm PCMR CANMET. The 
relative elrmmt contear in the sample is ar folows: 
Ni 1.233 @/.; Cu. 0 967 @A; Co 0.041 w%; 4 0.41 uglg: Pd. 0.37 uglg, Ag. 4.30 uglg. 
It is wotth noting that nicM ore consists of a mhture of metals and the rerponsc of 
organinnrto it mayhequ i f c~aan to  the rerpowe oforsanism to pure mnal compounds 
that are d in most studies. Since nicM and soppa are the d o h t  Components in the 
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sample, the final toxic nrpoma to nickel on mi@ be due to the spagjstic or antagonisis 
action betweenNi and Cu. Howwer, thir does not rule out the #Tern exerted by the other 
metals. Also, t h e m a ~ a  in which nickel is complexed in the ore and iu mlubiliry (or lackof 
it) d have a nigni6-t impact on how it &ens orgadorns. In thir regard, the etfects of 
nickd ore may resemble thore ofnickel subsulfide since the latter is also imoluble. 
Fmnth=sowrall review ofthe d t r  ofnidrel ore, it a p p m  that nickel ore does not 
*st LPO, pmtein sarbonyl contat. ALA dehydrafase, CAT, SOD. GSH-Px, GSR O R  
GST (DCNB, EAA. trans4phenyl-3-buten-3irns) in rat liver or kidney to any signi6cant 
extent Agnat ~onintheactivitititi of SOD and GR were obseeed b w n  the various 
conaol groups and so in replicate experiments. The reason for thir variation is not clear 
Samples from both contml and treated groups within a single experiment wen  analyzed on 
the same day wing the spme batch of reams H o w r ,  samples h m  di&mnt experiments 
were analyzed at d i m t  timu wing mshly made reagents each time. This should not 
normally lead to large d i 2 f e ~ a 0  in activity iu was obscwed in someiisansfeg. In the case 
of replicate experiments, where a statistical si@isanse was o b d  it was m ~ n a l  and 
\uas not reen in repeat experiments possibly due to high standard dwiation. A statistically 
 cant^^ obsnved in l i v r  NADV)H. qvinone redunaxactivity in the group 
a a t e d  with 200 W r a t  (2 w): the enhancement rate averaged 111%. An incrsa~e also 
oaurred in kidney GST(CDNB) acfivity in the gmups aated with LOO and 200 W m t  (2 
d) and thir activation seemed to be indued in a doredependent manner 
LPO and protein &nyl levels in biological tisues represmt oxidative damage to 
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lipid and protein. The lack of alteration of t h m  rwo paramaerr &er nickel ore 
adminirwhnsuggestr that the oxidative damage is not involved in the toxicity repon= of 
rats to nickel ore exposure under the +c dosage and duration regimeos set in my 
nwarch H o w ,  his does not rule m the p ~ n i t y  that oxidative d-gc may be evidmt 
under other cimxwf~nnas (e.g. diircnr dosage or duration prior ro sarritice). It has been 
aablishedthat Ulae isadirrct datioluhip baweenLP0 and tissue iron and copper content, 
inwlving react= oxygenrpeciu Nickel treament may also auist in generation ofnctivated 
-n rpecieg (Mimet 01.. 1990). It is quite reasonable to aswme that an i n m e  in LPO 
I d s  d d  &f 6omthemmbiitionNi and Cu (e.g. nickel ore), especiauy since m p p r  
is h w n  to redox syc1ebeme.m CU (n) and Cu (I) (Patel el  a!., 1997). Howwer, this war 
not the s m .  The r-n wuld be amiute to low concmuation of nickel or w p p a  i i  the 
kidney and liver bec-e of the low mlubility of nickel or coppacomplex in the ore. 
Aaordii  to the report by Mirra a al. (19901, three houn &er intrapecitoneal 
adminimtion of nickel acetate to male F 344NCr rats there was increased LPO Iwclr. 
decreased CAT and GSH-Px activity, decread GSH levels and d e w  GR activity in 
both livm and Iddney. The wncurrrncs ofLPO increase and dewease in the activity of H,Or 
m-gsln~ep (e.g. CAT and GSH-Px) could augment the potential cellularoxidative 
damage. The tissue GSH Level flumates with the lwelr of GSH synthesis and metabolism 
enzymes (eg. GR GSH-W GST). Interaction of metals with glutathione maabolirm is an 
integral pan of the toxic response of many mads (Cartam el el.. 1992). It is know that 
GSH plays several impomt mles which inclvde the maintenance of suIfhydry1 enzyme% 
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intemity ofmembrane against pemxidarin damage. regulation ofandno add transport and 
maintenance of inuacellcelllar Rdox potential (Athnr er 01.. 1987). Coppa could pmduce a 
drastic dmp of the GSWGSSG ratio in both tiw and kidney Renal GST iditition and 
hepatic GR inhibition was also obwrved (Cartulaerd, 1992). My rcsvlrr indicatc that the 
dfect of nickel ore on the antioxidant deface system is not rigdlicant. Tbh resvlt is in 
Leepingwith my observations that LPO and protein carbony1 content are not changed. This 
may be due to the difference in action behvem soluble and insoluble nickel compounds 
Again ~ m u t u o f a d m i n i ~ t i o n ,  utritional sate and the ten compound used could 
explain the dimpanciu. 
Nickel exporun could also cause ALA dehydratax inhibition thus inducing a 
pmdx40nin heme m e a b o l i s m m  1980). A h ,  heme is thc main constiruent of many 
detoxifying enzym=s, e g. CAT. pemddases and cytochmme P450. The lack of change in 
ALAdeSydratdJeis in keeping with the lack in CAT and GSH-Px activities after nickel ore 
nponure. 
Interestingly. a si&iont increme w a ~  ob~srvsd in lddnsy GST (CDNB) in the 
gmuprueated wah 1W and 2W @rat (2 0. The a M o n  seemed to be inddced in B do* 
dependent manner The GSTr are a p u p  of multifunctional e v e r ,  with bmadly 
overlapping substme rpec%icitien, which are generally involved in the detodflcation ofthe 
advated el-philic mobiotiss (Iscan crrrl.. 1992: Iscan er ol. 1993). GST aniviticr for 
DCNB, EAA and trans4phenyl-3-buten-3-one are relatively specific meawes of rat liver 
i s o w s  3-3,7-7 and 4-4. CDNB is the most important nubstrate forthe demonstration of 
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multiple forms of OST (Manned and Danielros 1988). Admini-tion ofnickel chloride 1 
wbcutaneourly 16 hr prior to saaificc m qotted to increase hepatic GST (FAA) wide 
exening no e&a on GST(CDNB and DCNB) ( b a n  ecol, 1992). Adminisuation of nickel 
antateimraperimDeauy 3 h p M r  to d c e  was reported to increase kidney GST (CDNB) 
by 44% ( Wsra rr =I.. 1990). In the Nmnf mdy, the observed mhmcement of GST 
(CDNB) a d v i ~ ~  and the !a& o f a l t d o n  GST (DCNB, EEA and wns-%pheoyl-3hten-3- 
one) activity was good manimfation for the differrotid reBulation of i r o ~ n e r  of GSTs by 
Nl in rat liwr and kidney. If is notmnhy t h e  copper could induce L cocosiderable ih'bition 
in kidney GST (CDNB) ~(~ ef111.. 1992). The response ofmts in GSTT may be 
due to the combination e&aofnidrel and W e r  in nickel ore. The innease in GST activity 
~uggests the ability of raf kidney to cope with the insult of nickel ore by inueaslng its 
detoxifying capacity. 
NAD(P)H: quinone ducrase is often regarded ar a phase U detoscation system. 
It is SY-ed chat this enzyme could help maintain coenzyme Q in the redused form hence 
recycling it as an inhibitor of lipid pemddation (Halliwell and Gunmidge, 1999). In Ihe 
s u m 1  study, a statistically d&- increase wap observed in livpr NAD(P)H- qvinone 
rrductanc activity in the -p neafed with 200 m9,raf (2 2); the enhancement rate averaged 
11% %could b e l d b e r e g a r d e d ~ ~ a n ~ i n t h e t i ~ ~ d p t o ~ f y i n g ~ ~ p ~ ~ i t y u n d e r n i c k e I  ore 
i"Su1t. 
Overall, nickel wbndKde suppressed antionidant defence mrymer by inhibiting 
hepatic CAT and SOD. Nickel ore g s 4  did not cause substantial changes although 
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kidney GST (CDNB) and d NADplH: quinone rsducfaJs activities were increased. I t  
appearsthat nickelore does not pose an evident toxic i n d t  to rats in short term ~Ndies and 
hence the risk p o d  to aquatic speciu may be minid based on the* d i e s .  However, 
long-term studies using rainbow vout and bid- need to be conducted to invssdgate 
possible risks ofmore broadde environmental concern. 
5. CONCLUSION 
&kel nrbwEde administration (200 rn9,raf sin& or twice dose. 2 w) supprcawd 
h+c CAT and SOD which covld compmmine the biological antioddant system 
NicM ore doer not aSe3 LPO, pmte iodony l  content. ALA dehydrata~e, CAT, 
SOD, Om-m GSH GR GSTipCNB, EA4 tranr-4-phenyl;l-buten-3+ne) in rat 
liver and kidney to any s i d c a n t  exfent. 
Nickel ore induced a statistidy significant in-e in liver NAW)H: quinone 
red- d t y  inthegmup treated with 200 mglrat (2 w) A significant insnare 
oaurred in kidney GST(CDNl3) in the groups t m r e d  with 100 and 200 mglrat (2 d) 
andtheadvationseamed to be dorc-dependolt. Theincrease in these activities could 
help b w n  the pmteaiw capacity of the rats. 
It appears that nickel ore doer not pore an evident toxic insult to rats in shon term 
d i e s  and hence therisk posed to aquatic species could be minor. Howwer, furths 
savdien with rainbow aout needto be conducted to investigate possible r i s k  ofmore 
bmadsale environmand concern: 
. It h proposed to prepare &gn &om Ule authentic ore a d  analyze its uptake 
and potentid toxiciw. Short-term and Eong-term in V i l a  studies in rainbow 
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mu d b e c a n i e d  cut Tmut will be either injected (i-p.) by a suspmrio~ of 1 
tailings or orpored to diluted leashate in 3M) L tanks for a period of i to 2 
weelo. Tailings with partide h e  less than 5 microns wiU also mixed with 
sand atthe bnmm ofthe & to obrwetheeiTea &a I to 4 months Livers 
and kidncyr will be removed and aliquotr -red to measure lipid 
pemxidation &&one 1-lr, oxidam and antioxidam enzymes. Cu and Ni 
antent inthe 6sruerwill bemeasured ar well. Neuuophils mi be isolated to 
mpaaurthe rupiratotyburrt. Di%kential blood 4 m o t s  will be measured 
as an indication of immvnoiogic manges. 
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